Intraday Investments Stalk Sheet for Wednesday, October 10, 2001
In the after hours markets the Nasdaq Futures are down 4.50 pts. and the S&P Futures are down 1.50 pts as of 1:08 am edt.
Companies in our sector model reporting earnings on Wednesday include: ABT, INFY, MTG, STI, DNA, WIN, YHOO and RBAK.
On the economic calendar for Wednesday we have: 10:00 am : Wholesale Inventories for August.
LONGS:
SEPR, Sepracor, Long > 39.45, Biotech Sector-Pharm. Processing, $BTK.X
With big volume and above this 5 day high, SEPR should break out the 40.75 area. Volume will be the key for this one as it could form a double top and become a short play.
GENE, Genome Therapeutics, Long >6.90, Biotech Sector-Genetic Mapping, $BTK.X
GENE broke above a 4 day band of consolidation on strong volume on Tuesday and closed at the high of the day. Next minor resistance is at 6.90. Above here we should see the 7.50 area.
SHORTS
EBAY, Ebay, Inc, Short < 54.10, Internet Sector-eCommerce, $IIX.X
Below here we break the 200 ma on the 5 min chart and should be able to take out Tuesday’s low of 53.89. Next Support is at 52.70
BBY, Best Buy, Short < 46.79, Retail Sector-Electronics, $RLX.X
Below Tuesday’s low we break the 200 ma on the 5 and 15 min charts. Would also consider shorting this one on light volume gap up or rally near 47.75.
Trade Well Today!
Ed, Steve & Deron
General Partners
intradayinvestments.com
Disclaimer: Intraday Investments does not advise its clients or any other person whether or not to buy or sell or take positions in securities. Further, we do not receive any form of payment or other compensation for publishing information, news, research or any other material concerning any securities on our site or publish any information on our site that is intended to affect or influence the value of securities.
We are not registered as a broker, broker-dealer, investment adviser, agent or representative of the U.S. Securities and Exchange Commission, or any similar authority. We do not teach or recommend to any Client their financial suitability to trade equities. We make and offer no analysis or advice regarding your individual financial suitability to trade equities as a day trader or otherwise. We are not responsible for what any Client does based on our opinions. |
